GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug applications ...
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer preve ...
GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...